Kanabo Group PLC Treat It Launch: Online Medicinal Cannabis Clinic (6440S)
13 Março 2023 - 4:00AM
UK Regulatory
TIDMKNB
RNS Number : 6440S
Kanabo Group PLC
13 March 2023
13 March 2023
Kanabo Group plc
("Kanabo", the "Group" or the "Company")
Launch of 'Treat It' an Online Medicinal Cannabis Clinic for
Pain Management
'Treat It' clinic enables patients to access healthcare
professionals via Kanabo's secure, digital healthcare platform
Chronic pain sufferers to be given access to medicinal cannabis,
directly addressing growing demand across the UK for pain
management
Kanabo Group plc (LSE: KNB), a patient-focused Healthtech
company, has launched Treat It , a new online medicinal cannabis
clinic for pain management. The new clinic aims to address the
issue of limited access to pain management treatments for the
approximately 8 million chronic pain sufferers in the UK. These
individuals face difficulties accessing medical treatments due to
long waiting times, bureaucracy, and affordability. According to
recent data, 24% of chronic pain sufferers in the UK are currently
being prescribed opioids, making up approximately 3 million of the
potential patients who can benefit from switching to medicinal
cannabis.
Treat It enables patients to access healthcare professionals via
Kanabo's secure, digital healthcare platform. It will be focused on
secondary care, including the prescription of medicinal cannabis.
Studies have shown that medicinal cannabis can relieve pain for a
range of common chronic pain conditions. Kanabo's existing online
clinic, The GP Service, offers patients access to experienced
healthcare professionals who can offer a broad range of treatment
recommendations for primary care.
The growing demand for pain management treatments using
medicinal cannabis is reflected in the increase in medical cannabis
prescriptions issued in the UK, with over 89,000 issued between
November 2018 and July 2022, indicating an average growth rate of
approximately 72% per year, with more than 100% growth in 2022.
Avihu Tamir, CEO of Kanabo Group said:
"Our innovative healthcare platform, Treat It, seeks to directly
address the limited access to pain management treatments for
patients across the UK. Leveraging our proprietary technology from
The GP Service, which we have recently integrated, we have created
an online ecosystem for chronic pain sufferers, providing access to
doctors and medicinal cannabis prescriptions. Our goal is to offer
patients direct access to high-quality medical treatments;
empowering patients to take control of their own personalised
care."
Treat It forms part of the Company's growing technology stack,
and combines proprietary digital tools and a treatment portfolio,
including patient access, online consultations, prescriptions, and
medication dispensing, into an integrated end-to-end solution. This
unified approach offers patients efficient and effective access to
qualified medical practitioners. Kanabo's treatment portfolio
focuses on pain management using medications and treatments,
including medicinal cannabis, which is currently unavailable
through traditional channels. However, demand for these products is
growing as patients seek alternative pain management options.
Treat It is regulated by The Care Quality Commission and
certified with ISO 27001 for information security, will allow
doctors registered with the General Medical Council to prescribe
medicinal cannabis to patients while following the guidelines set
out by the National Institute for Health and Care Excellence.
Enquiries:
Kanabo Group plc via Vigo Consulting
Avihu Tamir, Chief Executive Officer +44 (0)20 7390 0230
Assaf Vardimon, Chief Financial Officer
Peterhouse Capital Ltd (Financial Adviser)
Eran Zucker / Lucy Williams / Charles Goodfellow +44 (0)20 7469 0930
Vigo Consulting (Financial Public Relations/Investor
Relations)
Jeremy Garcia / Fiona Hetherington / Verity
Snow +44 (0)20 7390
kanabo@vigoconsulting.com 0230
About Kanabo Group Plc
Kanabo Group Plc (LSE:KNB) is a Healthtech company committed to
revolutionising patient care through its innovative technology
platform and disruptive product offerings. Since its inception in
2017, Kanabo has been focused on researching, developing, and
commercialising regulated medicinal cannabis-derived formulations
and therapeutic inhalation devices.
Kanabo's NHS-approved online telehealth platform, The GP
Service, provides patients with video consultations, online
prescriptions, and primary care services. The company is a leader
in its field, focusing on improving patient outcomes and providing
more accessible healthcare experiences.
In March 2023, Kanabo successfully launched its Pain Clinic,
Treat It, under the expert guidance of its technological and
product expertise. Treat It initially focuses on chronic pain
management using plant-based medicine and treatments that are
currently unavailable through traditional channels.
At Kanabo Group Plc, we are dedicated to providing patients with
the highest quality medical treatments and more accessible
healthcare experiences.
Visit www.kanabogroup.com for more info.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
PRLDBLFFXXLFBBL
(END) Dow Jones Newswires
March 13, 2023 03:00 ET (07:00 GMT)
Spinnaker Opportunities (LSE:SOP)
Gráfico Histórico do Ativo
De Fev 2025 até Mar 2025
Spinnaker Opportunities (LSE:SOP)
Gráfico Histórico do Ativo
De Mar 2024 até Mar 2025
